Position in KYTX
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$263,491
New position
Shares Held
30,532
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Banque Cantonale Vaudoise holds $13,170,474 across 21 Biotechnology names. KYTX ranks #12 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,927 | $3,986,262 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,978 | $1,977,940 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,970 | $1,522,100 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
16,000 | $903,840 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
17,463 | $830,714 | |
| 6 | INSM |
INSMED Inc
|
3,923 | $641,488 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
23,916 | $453,447 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
862 | $451,231 |
All Filings in KYTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $263,491 | 30,532 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||